Rating Change
RBC Capital reiterated its Underperform rating on Amrize Ltd (NYSE:AMRZ) on October 09, 2026.
RBC Capital reiterated its Underperform rating on Amrize Ltd (NYSE:AMRZ) on October 09, 2026.

At publication ·
Amrize Ltd (NYSE:AMRZ) · reiterate
At a glance
RBC Capital reiterated its Underperform rating on Amrize Ltd (NYSE:AMRZ) on October 09, 2026.
Amrize Ltd operates in the Basic Materials sector. The stock currently trades at $36.20 with a market capitalization of $35.9B. The stock has declined 35.2% over the past 52 weeks.
Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Amrize Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 3 Buy, 5 Hold, 2 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 09, 2026 | RBC Capital | Underperform | N/A |
| Oct 05, 2026 | Truist Securities | Hold | N/A |
| Oct 05, 2026 | Wells Fargo | Equal-Weight | N/A |
| Oct 02, 2026 | Citigroup | Buy | N/A |
| Oct 01, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View AMRZ Stock Page
A rating of Underperform from RBC Capital reflects the analyst's outlook on Amrize Ltd (NYSE:AMRZ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AMRZ forecast page.
Current market data
NYSE · AMRZ
$37.82
Up: +$0.50 · +1.34%
Live quote updated
Keep reading